Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Bader

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|May 26, 2004
Structure of the molybdenum-cofactor biosynthesis protein MoaB of Escherichia coliGerd Bader, Mariola Gomez-Ortiz, Christoph Haussmann, et al.
Chemmedchem|September 15, 2021
A Step toward NRF2-DNA Interaction Inhibitors by Fragment-Based NMR MethodsSven Brüschweiler, Julian E Fuchs, Gerd Bader, et al.
Plant Physiology|August 13, 2003
Structure and properties of an engineered transketolase from maizeStefan Gerhardt, Stefanie Echt, Marco Busch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2012
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blockerFlavio Solca, Goeran Dahl, Andreas Zoephel, et al.
Journal of Molecular Biology|February 1, 2003
Biosynthesis of pteridines. Reaction mechanism of GTP cyclohydrolase IJorge Rebelo, Günter Auerbach, Gerd Bader, et al.
Cancer Research|June 19, 2008
BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacyFrank Hilberg, Gerald J Roth, Martin Krssak, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2020
PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR SpectroscopyGerald Platzer, Moriz Mayer, Andreas Beier, et al.
Journal of Cell Science|April 25, 2018
Expansion of DUB functionality generated by alternative isoforms - USP35, a case studyPawel Leznicki, Jayaprakash Natarajan, Gerd Bader, et al.
Molecular Cancer Therapeutics|February 27, 2016
A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue HyperproliferationIrene C Waizenegger, Anke Baum, Steffen Steurer, et al.
Life Science Alliance|May 30, 2020
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancersPetra van der Lelij, Joseph A Newman, Simone Lieb, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Acta Crystallographica. Section D, Biological Crystallography|May 26, 2004
Structure of the molybdenum-cofactor biosynthesis protein MoaB of Escherichia coliGerd Bader, Mariola Gomez-Ortiz, Christoph Haussmann, et al.
Chemmedchem|September 15, 2021
A Step toward NRF2-DNA Interaction Inhibitors by Fragment-Based NMR MethodsSven Brüschweiler, Julian E Fuchs, Gerd Bader, et al.
Plant Physiology|August 13, 2003
Structure and properties of an engineered transketolase from maizeStefan Gerhardt, Stefanie Echt, Marco Busch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2012
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blockerFlavio Solca, Goeran Dahl, Andreas Zoephel, et al.
Journal of Molecular Biology|February 1, 2003
Biosynthesis of pteridines. Reaction mechanism of GTP cyclohydrolase IJorge Rebelo, Günter Auerbach, Gerd Bader, et al.
Cancer Research|June 19, 2008
BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacyFrank Hilberg, Gerald J Roth, Martin Krssak, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2020
PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR SpectroscopyGerald Platzer, Moriz Mayer, Andreas Beier, et al.
Journal of Cell Science|April 25, 2018
Expansion of DUB functionality generated by alternative isoforms - USP35, a case studyPawel Leznicki, Jayaprakash Natarajan, Gerd Bader, et al.
Molecular Cancer Therapeutics|February 27, 2016
A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue HyperproliferationIrene C Waizenegger, Anke Baum, Steffen Steurer, et al.
Life Science Alliance|May 30, 2020
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancersPetra van der Lelij, Joseph A Newman, Simone Lieb, et al.
Pageof 4